Hunan Hansen Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002412.SZ

Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow Yield on January 27, 2025: 4.85%

Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow Yield is 4.85% on January 27, 2025, a 0.29% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Hunan Hansen Pharmaceutical Co., Ltd. 52-week high Free Cash Flow Yield is 6.67% on February 07, 2024, which is 37.58% above the current Free Cash Flow Yield.
Hunan Hansen Pharmaceutical Co., Ltd. 52-week low Free Cash Flow Yield is 4.31% on October 08, 2024, which is -11.17% below the current Free Cash Flow Yield.
Hunan Hansen Pharmaceutical Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 5.08%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 002412.SZ

Hunan Hansen Pharmaceutical Co., Ltd.

CEO	Mr. Zhengqing Liu
IPO Date	May 25, 2010
Location	China
Headquarters	No. 2688, Yincheng Avenue
Employees	1,536
Sector	Health Care
Industries Pharmaceuticals

Description

Hunan Hansen Pharmaceutical Co., Ltd. produces and sells Chinese and chemical medicine preparations in China and internationally. It provides medicines in injection, oral liquid, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. The company is based in Yiyang, China.

Key trends

Past 5 years